Showing results (131-140 of 2,436) with videos related to
Sort By:
Pageof 244
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.The American Journal of Cardiology|November 15, 1985
Spectrum of antiarrhythmic response to encainideH J Duff, D M Roden, E L Carey, et al.Clinical Pharmacology and Therapeutics|September 16, 2011
Pharmacogenomics: application to the management of cardiovascular diseaseJ A Johnson, L H Cavallari, A L Beitelshees, et al.Circulation|December 16, 1998
Modulation by dietary salt of verapamil disposition in humansD Darbar, M F Fromm, S Dell'Orto, et al.Clinical Pharmacology and Therapeutics|March 1, 1986
Co-inheritance of the polymorphic metabolism of encainide and debrisoquinR L Woosley, D M Roden, G H Dai, et al.Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.Circulation|September 6, 2001
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromesP C Viswanathan, C R Bezzina, A L George, et al.Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.Journal of the American College of Cardiology|April 1, 1992
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-IIH L Greene, D M Roden, R J Katz, et al.Pageof 244